Tokuyama : Presentation for the Third Quarter Fiscal 2021
January 30, 2022 at 07:11 pm EST
Share
Q3 Fiscal 2021 - Apr 1, 2021 to Dec 31, 2021-
Presentation for IR Meeting
January 31, 2022
Key points of the third quarter of fiscal 2021
Despite a year-on-year increase in sales of semiconductor- and healthcare-related products as well as such factors as an increase in the price of petroleum products, earnings decreased as a result of upswings in fuel and raw material prices as well as costs including logistics expenses
Although the total performance forecast has not been revised, the breakdown by segment is revised mainly based on the actual results up to Q3 fiscal 2021
Continue to focus on efforts aimed at achieving the performance forecasts for fiscal 2021, by taking such measures as the revision of sales prices to recover the increase in costs
Steadily implemented growth strategies to achieve business portfolio transformation, including expansion the IC Chemicals business by establishment of a high-purity IPA joint venture company in South Korea
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Tokuyama Corporation published this content on 31 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 January 2022 00:10:06 UTC.
Tokuyama Corporation specializes in manufacturing and marketing chemical products. Net sales break down by family of products as follows:
- staple chemical products (28%): primarily caustic soda, sodium chlorite, calcium chloride, polyvinyl chloride, polypropylene and methylene;
- fine chemistry products (14.6%): primarily for the manufacturing of packaging, dental care equipments and clinical analysis systems;
- specialty chemical products (15.1%): detergents, emulsifiers, additives, chemical intermediates, etc.;
- other (12.5%).
The remaining sales (29.8%) are from the cement production activity.
At the end of march 2021, the group had 10 production sites located in Japan (2) and Asia (8).
Net sales are distributed geographically as follows: Japan (78.9%), Asia (17.1%) and other (4%).